These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

419 related items for PubMed ID: 17679815

  • 1. Polycystic ovarian syndrome.
    Khan KA, Stas S, Kurukulasuriya LR.
    J Cardiometab Syndr; 2006; 1(2):125-30; quiz 131-2. PubMed ID: 17679815
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME - PART 2.
    Goodman NF, Cobin RH, Futterweit W, Glueck JS, Legro RS, Carmina E, American Association of Clinical Endocrinologists (AACE), American College of Endocrinology (ACE), Androgen Excess and PCOS Society.
    Endocr Pract; 2015 Dec; 21(12):1415-26. PubMed ID: 26642102
    [Abstract] [Full Text] [Related]

  • 4. Polycystic ovary syndrome: reviewing diagnosis and management of metabolic disturbances.
    Spritzer PM.
    Arq Bras Endocrinol Metabol; 2014 Mar; 58(2):182-7. PubMed ID: 24830595
    [Abstract] [Full Text] [Related]

  • 5. Metabolic consequences of obesity and insulin resistance in polycystic ovary syndrome: diagnostic and methodological challenges.
    Jeanes YM, Reeves S.
    Nutr Res Rev; 2017 Jun; 30(1):97-105. PubMed ID: 28222828
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Polycystic ovary syndrome: pathophysiology, molecular aspects and clinical implications.
    Nardo LG, Patchava S, Laing I.
    Panminerva Med; 2008 Dec; 50(4):267-78. PubMed ID: 19078868
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Cardiometabolic risks in PCOS: a review of the current state of knowledge.
    Kakoly NS, Moran LJ, Teede HJ, Joham AE.
    Expert Rev Endocrinol Metab; 2019 Jan; 14(1):23-33. PubMed ID: 30556433
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Cardiometabolic biomarkers in women with polycystic ovary syndrome.
    van der Ham K, Louwers YV, Laven JSE.
    Fertil Steril; 2022 May; 117(5):887-896. PubMed ID: 35512973
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Polycystic ovary syndrome and insulin: our understanding in the past, present and future.
    Mayer SB, Evans WS, Nestler JE.
    Womens Health (Lond); 2015 Mar; 11(2):137-49. PubMed ID: 25776288
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Polycystic ovary syndrome. New pathophysiological discoveries--therapeutic consequences].
    Svendsen PF, Nilas L, Nørgaard K, Madsbad S.
    Ugeskr Laeger; 2005 Aug 22; 167(34):3147-51. PubMed ID: 16117910
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.